The paper focuses on big data and healthcare pharmaceuticals, which pose both great promise and challenge as they can contribute to well-being and deliver innovation and knowledge to next-generation healthcare products. This paper provides an overview of the benefits that machine learning and big data technology contribute to healthcare systems. Realities such as patient and healthcare professional demands, the number of diseases, insufficient drugs, regulations, legal and ethical guideline restrictions, modus operandi, and technology development take place in the healthcare sector. In addition, big data opportunities and challenges for healthcare companies, research, and healthcare infrastructure are discussed. Finally, a vision of health innovation through personalized medicines as well as smart medicine is presented as a step closer to patients through regulatory, legal, and ethical guidelines, applications, and opportunities that need to be regulated and resolved.
Read full abstract